National Institutes of Health Director Dr. Jay Bhattacharya discusses President Donald Trump's actions to lower prescription drug prices and his...
drug
Few medications have made the kind of dramatic entrance to the public sphere that semaglutide (GLP-1) and tirzepatide (GIP) have,...
